Bank of New York Mellon’s Pliant Therapeutics PLRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.6K | Sell |
16,035
-156,990
| -91% | -$182K | ﹤0.01% | 4095 |
|
|
2025
Q1 | $234K | Sell |
173,025
-11,357
| -6% | -$15.3K | ﹤0.01% | 3795 |
|
|
2024
Q4 | $2.43M | Sell |
184,382
-172
| -0.1% | -$2.27K | ﹤0.01% | 2662 |
|
|
2024
Q3 | $2.07M | Sell |
184,554
-44,139
| -19% | -$495K | ﹤0.01% | 2719 |
|
|
2024
Q2 | $2.46M | Buy |
228,693
+29,629
| +15% | +$319K | ﹤0.01% | 2679 |
|
|
2024
Q1 | $2.97M | Sell |
199,064
-11,576
| -5% | -$172K | ﹤0.01% | 2563 |
|
|
2023
Q4 | $3.81M | Buy |
210,640
+10,416
| +5% | +$189K | ﹤0.01% | 2501 |
|
|
2023
Q3 | $3.47M | Buy |
200,224
+15,578
| +8% | +$270K | ﹤0.01% | 2512 |
|
|
2023
Q2 | $3.35M | Buy |
184,646
+159,258
| +627% | +$2.89M | ﹤0.01% | 2554 |
|
|
2023
Q1 | $675K | Buy |
25,388
+10,711
| +73% | +$285K | ﹤0.01% | 3326 |
|
|
2022
Q4 | $284K | Sell |
14,677
-20,437
| -58% | -$395K | ﹤0.01% | 3817 |
|
|
2022
Q3 | $733K | Buy |
35,114
+24,544
| +232% | +$512K | ﹤0.01% | 3361 |
|
|
2022
Q2 | $85K | Sell |
10,570
-62,729
| -86% | -$504K | ﹤0.01% | 4259 |
|
|
2022
Q1 | $513K | Sell |
73,299
-163
| -0.2% | -$1.14K | ﹤0.01% | 3688 |
|
|
2021
Q4 | $992K | Sell |
73,462
-1,008
| -1% | -$13.6K | ﹤0.01% | 3391 |
|
|
2021
Q3 | $1.26M | Buy |
74,470
+15,180
| +26% | +$256K | ﹤0.01% | 3267 |
|
|
2021
Q2 | $1.73M | Sell |
59,290
-116,658
| -66% | -$3.4M | ﹤0.01% | 3089 |
|
|
2021
Q1 | $6.92M | Buy |
175,948
+81,497
| +86% | +$3.21M | ﹤0.01% | 2286 |
|
|
2020
Q4 | $2.15M | Buy |
94,451
+8,261
| +10% | +$188K | ﹤0.01% | 2804 |
|
|
2020
Q3 | $1.95M | Buy |
86,190
+66,048
| +328% | +$1.5M | ﹤0.01% | 2683 |
|
|
2020
Q2 | $654K | Buy |
+20,142
| New | +$654K | ﹤0.01% | 3335 |
|